This inventor holds 2 USPTO granted patents. Top assignee: Northwestern University. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: The Innovative Contributions of Matthew R. Clutter
Introduction
Matthew R. Clutter is a notable inventor based in Deerfield, Illinois. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific kinases involved in various diseases. With a total of two patents to his name, Clutter's work is paving the way for new treatment options.
Latest Patents
Clutter's latest patents include innovative compounds that serve as selective inhibitors for specific kinases. The first patent focuses on 3-arylindazoles as selective MEK4 inhibitors. These indazole compounds and their derivatives are designed to modulate the activity of mitogen-activated protein kinase 4 (MEK4). The compounds may be formulated into pharmaceutical compositions aimed at treating cell proliferative diseases, including cancer. The second patent involves substituted aromatic n-heterocyclic compounds that inhibit mitogen-activated protein kinase interacting kinase 1 (MNK1) and 2 (MNK2). These compounds exhibit kinase inhibition activity and may be utilized in treatments for diseases associated with MNK1 and MNK2 activity, such as cancers, diabetes, autism, and fragile X syndrome.
Career Highlights
Matthew R. Clutter is affiliated with Northwestern University, where he conducts research and develops his innovative compounds. His work is characterized by a strong focus on addressing critical health issues through targeted therapies. Clutter's contributions to the field have been recognized for their potential impact on treatment methodologies.
Collaborations
Clutter has collaborated with esteemed colleagues, including Gary E. Schiltz and Javier Izquierdo-Ferrer. These partnerships enhance the research and development process, allowing for a more comprehensive approach to innovation in pharmaceuticals.
Conclusion
Matthew R. Clutter's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents reflect a commitment to developing effective treatments for serious health conditions. Through his research at Northwestern University and collaborations with other experts, Clutter continues to make strides in the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile